Bringspring Science and Technology (SZSE:300290) Investors Are up 8.1% in the Past Week, but Earnings Have Declined Over the Last Three Years
Bringspring Science and Technology (SZSE:300290) Investors Are up 8.1% in the Past Week, but Earnings Have Declined Over the Last Three Years
For us, stock picking is in large part the hunt for the truly magnificent stocks. Not every pick can be a winner, but when you pick the right stock, you can win big. One bright shining star stock has been Bringspring Science and Technology Co., Ltd. (SZSE:300290), which is 319% higher than three years ago. Also pleasing for shareholders was the 132% gain in the last three months. The company reported its financial results recently; you can catch up on the latest numbers by reading our company report.
對於我們來說,股票選擇在很大程度上是在尋找真正優秀的股票。並非每次選擇都會成功,但當你選對了股票,你將會贏得大獎。一個明星股票就是榮科科技股份有限公司(SZSE:300290),比三年前高出319%。同時令股東高興的是過去三個月上漲了132%。公司最近發佈了財務報告;您可以通過閱讀我們的公司報告了解最新數據。
Since the stock has added CN¥1.2b to its market cap in the past week alone, let's see if underlying performance has been driving long-term returns.
鑑於該股市值僅過去一週就增加了人民幣12億,讓我們看看是否潛在表現推動了長期回報。
We don't think that Bringspring Science and Technology's modest trailing twelve month profit has the market's full attention at the moment. We think revenue is probably a better guide. Generally speaking, we'd consider a stock like this alongside loss-making companies, simply because the quantum of the profit is so low. It would be hard to believe in a more profitable future without growing revenues.
我們認爲榮科科技的過去十二個月的微薄盈利目前並沒有市場的充分關注。我們認爲營業收入可能是更好的指導。總的來說,我們會將這樣的股票與虧損公司放在一起考慮,僅因爲利潤數量如此之低。在沒有增長營收的情況下很難相信將有更加盈利的未來。
Bringspring Science and Technology actually saw its revenue drop by 4.1% per year over three years. So it's pretty amazing to see the stock price has zoomed up 61% per year in that time. There can be no doubt this kind of decoupling of revenue growth and share price growth is unusual to see in loss making companies. So there is a serious possibility that some holders are counting their chickens before they hatch.
榮科科技實際上看到其營業收入在過去三年中每年下降4.1%。因此,在此期間,看到股價每年飆升61%,確實令人驚訝。毫無疑問,在虧損公司中看到營收增長與股價增長脫鉤的情況是飛凡的。因此,某些持有者可能在未卵化前數雞。
The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).
下面的圖表顯示了收益和營收隨時間的變化情況(通過單擊圖像揭示確切的值)。
Take a more thorough look at Bringspring Science and Technology's financial health with this free report on its balance sheet.
通過這份免費報告,更全面地了解榮科科技的財務狀況。
A Different Perspective
不同的觀點
It's nice to see that Bringspring Science and Technology shareholders have received a total shareholder return of 231% over the last year. That's better than the annualised return of 32% over half a decade, implying that the company is doing better recently. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For example, we've discovered 2 warning signs for Bringspring Science and Technology (1 makes us a bit uncomfortable!) that you should be aware of before investing here.
很高興看到榮科科技的股東在過去一年中獲得了總股東回報率231%。這比過去五年32%的年化回報率要好,這意味着公司最近表現更好。鑑於股價勢頭依然強勁,值得更仔細地觀察股票,以免錯失機會。雖然考慮市場狀況對股價可能產生的不同影響非常重要,但還有其他更重要的因素。例如,我們發現了榮科科技的2個警示信號(其中1個讓我們有點不舒服!),在投資這裏之前,您應該留意。
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.
如果您願意查看另一家公司(具有潛在的更好財務狀況),請不要錯過這個免費的公司列表,證明它們可以增長收益。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
請注意,本文引用的市場回報反映了目前在中國交易所上市的股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。